The Top Prescription Drugs of 2012 Globally: Biologics Dominate, But Small Molecule CNS Drugs Hold on to Top Spots

ADVERTISEMENT RETURN TO ISSUEEditorialNEXTADDITION / CORRECTIONThis article has been corrected. View the notice.The Top Prescription Drugs of 2012 Globally: Biologics Dominate, But Small Molecule CNS Drugs Hold on to Top SpotsCraig W. LindsleyCite this: ACS Chem. Neurosci. 2013, 4, 6, 905–907Publication Date (Web):June 19, 2013Publication History Published online19 June 2013Published inissue 19 June 2013https://pubs.acs.org/doi/10.1021/cn400107yhttps://doi.org/10.1021/cn400107yeditorialACS PublicationsCopyright © 2013 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views6469Altmetric-Citations28LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (186 KB) Get e-AlertscloseSUBJECTS:Peptides and proteins,Pharmaceuticals,Small molecules,Therapeutics Get e-Alerts